(Ginsheim/Gräfelfing) This month, the listed company PharmaSGP is transferring the warehousing, order picking and dispatch of selected branded products such as Spalt or Formigran to the logistics service provider Movianto, who specialises in the pharmaceutical and healthcare sectors. PharmaSGP, based in Gräfelfing near Munich, focuses on the development and distribution of non-prescription branded products. For quality assurance reasons, PharmaSGP has committed to full temperature control of the medicines it distributes.
“We are pleased that PharmaSGP has decided to work with us in the future, relying completely on active temperature control,” says Dennis Spamer, Managing Director of Movianto Germany. “Not only warehousing, but also dispatch to pharmacies and wholesalers is actively temperature-controlled at 15 to 25 degrees. This is still not standard for non-prescription OTC products.” According to Spamer, temperature control is playing an increasingly important role in the logistics of pharmaceuticals, but also increasingly of medical products. “We are experiencing steadily increasing demand for this and will further expand our capacity in this area next year.”
PharmaSGP is a leading consumer health company with a diversified portfolio of non-prescription OTC medicines and other health products marketed with a focus on the pharmacy distribution channel. The majority of the company’s medicines are based on natural active pharmaceutical ingredients with documented efficacy and few known side effects. The company’s core brands cover chronic indications, including rheumatic pain and nerve pain, as well as other age-related conditions. In Germany, PharmaSGP is the market leader in systemic, chemical-free analgesics with its RubaXX® family of brands for rheumatic pain and Restaxil® for neuralgic pain. In addition, PharmaSGP offers leading products for sexual weakness and vertigo. Since the launch of the first product from the current product portfolio in 2012, PharmaSGP has successfully established its business model in other European countries, including Austria, Italy, Belgium, Spain and France. In September 2021, the product portfolio was expanded to include the brands Baldriparan®, Formigran®, Spalt® and Kamol®, thus further expanding or developing the indication areas of pain and sleep disorders. In the 2021 financial year, PharmaSGP generated sales revenues of 65.3 million euros. www.pharmasgp.com
Since 2020 Movianto is part of the Walden Group. With its one-stop-shop service for the distribution of healthcare products, Walden is now Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto aims to be the preferred European logistics partner for this industry and to offer the best service for pharmaceutical as well as biotechnical products, for medical technology as well as for diagnostics. Along the logistics chain of such products, Movianto as an outsourcing partner offers, for example, warehouse logistics and transport (also temperature-controlled), but also complete solutions such as order to cash or purchasing and procurement services. Movianto’s international clients benefit from a pan-European network, a wide range of pharmaceutical logistics, unique industry know-how and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,700 people, has space for more than 275,000 pallets in its network of 20 company-owned logistics centres in eleven European countries and operates throughout Europe. www.movianto.com
Founded in 1951 in France, the Walden Group is a family-owned company whose ambition is to become a global player in supply chain and logistics. Its activities are grouped around two poles of expertise: on logistics and transport of health products (with Movianto for logistics, Eurotranspharma for temperature-controlled last mile transport and Transpharma International for first mile transport) and on express transport (with Ciblex, DPXS, Eco course Optic and Relais Colis). To support these activities, the subsidiary Pharma Pilot develops IT and digital solutions tailored to the specific needs of the group’s customers. The Walden Group is present in 16 countries (France, Spain, Germany, the Netherlands, Belgium, Denmark, England, Scotland, Wales, Northern Ireland, Ireland, Switzerland, Morocco, Poland, the Czech Republic and Slovakia), employs more than 6 000 people on 180 sites and nearly 800,000 m² of warehouses. In 2021 the group had a turnover of €1.9 billion.
Contacts for press enquiries:
Dennis Spamer Ludwig-Michael Cremer
Movianto Deutschland GmbH external press office Movianto
Tel +49 6134 5678 105 Tel +49 7071 640 315
We look forward to receiving digital or physical copies!
If you do not wish to receive further press releases from Movianto, please send a short email to email@example.com. Thank you!
Laure Murat | Marketing and Communication at Walden Group
We will be glad to support you with your information requirements.